Swedbank Ab Neurocrine Biosciences Inc Transaction History
Swedbank Ab
- $86.1 Billion
- Q2 2025
A detailed history of Swedbank Ab transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Swedbank Ab holds 503,502 shares of NBIX stock, worth $67.2 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
503,502
Previous 429,697
17.18%
Holding current value
$67.2 Million
Previous $47.5 Million
33.16%
% of portfolio
0.07%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
651Shares Held
97.3MCall Options Held
749KPut Options Held
553K-
Black Rock Inc. New York, NY14.2MShares$1.89 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.94MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.53MShares$739 Million0.37% of portfolio
-
State Street Corp Boston, MA4.86MShares$649 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$357 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.8B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...